在慢性阻塞性肺病中,减少RECK表达和中性质炎症之间的关联
Jiahui Wang1, Yi Su1, Hong Liu1
1Department of Pulmonary and Critical Care Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
International archives of allergy and immunology
|February 22, 2024
概括
在慢性阻塞性肺病 (COPD) 患者中,诱导逆转的卡扎尔基因 (RECK) 含有丰富的囊蛋白减少,并可能通过降低矩阵金属蛋白酶-9 (MMP-9) 的调节来抑制中性粒细胞炎症和迁移. 这一发现为COPD预防和治疗提供了新的基础.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 具有卡扎尔基因的逆转诱导氨酸丰富蛋白 (RECK) 是一个矩阵金属蛋白酶 (MMP) 抑制剂.
- 慢性阻塞性肺病 (COPD) 影响全球数以百万计的人,但RECK在COPD病原体中的作用仍未得到研究.
研究的目的:
- 为了研究COPD患者的RECK表达.
- 为了确定RECK对COPD中性粒细胞功能的影响.
- 为新的COPD治疗策略建立一个科学基础.
主要方法:
- 在COPD患者和健康对照组的肺组织,和血中分析了RECK表达,使用免疫组织化学,ELISA和qRT-PCR.
- 评估了肺功能 (FEV1%pred) 和炎症性细胞因子 (IL-6,IL-8).
- 包括增殖,亡,迁移和炎症性细胞因子释放在内的中性粒细胞功能被评估为对复合人类RECK蛋白 (rhRECK) 和香烟烟雾提取物 (CSE) 的反应.
主要成果:
- 与对照人群相比,COPD患者的气道上皮细胞,唾液和血中的RECK表达显著减少.
- 血RECK水平与肺功能正相关 (FEV1%pred),与IL-6和IL-8水平负相关.
- CSE减少了BEAS-2B细胞中的RECK表达,而rhRECK抑制了CSE诱导的中性粒细胞迁移,炎症和MMP-9表达.
结论:
- 在COPD患者中,RECK的调控下降,与炎症相反.
- 雷克可以通过抑制MMP-9对中性粒细胞产生抗炎和抗迁移作用.
- 向RECK可能是COPD管理的潜在治疗方法.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:38Inflammation
53.4K
Overview
53.4K